Wealth Enhancement Advisory Services’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Wealth Enhancement Advisory Services's ALT Position: Q3 2026 in Review
Wealth Enhancement Advisory Services sold out of Altimmune (ALT) in Q3 2026, closing a stake of 25,989 shares — an estimated $79.3K sold.
Wealth Enhancement Advisory Services first reported a position in ALT in Q2 2024 and held it in 6 quarters. The position peaked at $118K in Q2 2025. 191 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Wealth Enhancement Advisory Services reported no remaining Altimmune position as of Q3 2026 after selling out during the quarter.
- Wealth Enhancement Advisory Services sold 25,989 Altimmune shares in Q3 2026, an estimated $79.3K.
- Wealth Enhancement Advisory Services first reported a position in Altimmune in Q2 2024 and held it in 6 quarters.
- Wealth Enhancement Advisory Services's Altimmune position peaked at $118K in Q2 2025.
- 191 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.